MedPath
NMPA Approval

Afatinib Dimaleate Tablets

国药准字H20249612

December 1, 2024

Drug Information

马来酸阿法替尼片

片剂

30mg(按C₂₄H₂₅ClFN₅O₃计)

化学药品

December 1, 2024

Company Information

Applicant Company

甘肃省兰州市兰州新区昆仑山大道中段1739号

Manufacturing Company

甘肃省兰州新区昆仑山大道中段1739号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸阿法替尼片 - NMPA 批准文号 | MedPath